Learn from people with more than 10 years of experience

Resources

Link2Trials Q&A_6

Aad Liefveld
Q&A
57
hand-holding-questions-mark-on-wooden-cube-b-2022-11-07-22-16-58-utc-24051126364.jpg
24-05-2023 11:27
In this Q&A series we answer questions we have received from our customer base.   #6: Is there a role of patient advocacy groups in online patient recruitment? ‌ Patient advocacy groups play a crucial role in online patient recruitment by serving as intermediaries between patients and clinical trials. These groups often have a network of patients and advocacy organizations they...Read more

Link2Trials Q&A_5

Simon Klaasen
Q&A
96
hmm-so-much-to-think-about-2022-12-13-22-58-06-utc-12051427528.jpg
12-05-2023 14:28
In this Q&A series we answer questions we have received from our customer base.   #5: What is patient adherence in clinical trials, and why is it important?   Patient adherence refers to the degree to which a patient follows the instructions and requirements of a clinical study protocol. This can include taking medications as prescribed, attending study visits, completing study...Read more

Link2Trials Q&A_4

Marjolein Nankman
Q&A
96
question-and-answers-concept-wooden-alphabet-of-l-2022-09-28-20-04-48-utc-12051424076.jpg
12-05-2023 14:24
In this Q&A series we answer questions we have received from our customer base. #4: How does social media advertising target the right patient demographic for your clinical trial?   To target the right patient demographic through social media advertising, you can follow these steps: Define your target audience: Determine the age, gender, location, interests, and behaviors of your...Read more

Link2Trials Q&A_3

Edwin Swart
Q&A
101
faq-sign-on-wooden-peg-2021-08-27-23-44-48-utc-12051420234.jpg
12-05-2023 14:20
In this Q&A series we answer questions we have received from our customer base. #3: How do you know what the best visuals are for your online clinical study advertisements?   What are the actual thumb stoppers? We let the patients decide. In our creative brainstorming sessions, we develop many concepts that will work in a particular patient population. Then, we try these different...Read more

Interview Team members Beamer Project

Simon Klaasen
197
f2f2f2-2--14041632483.png
14-04-2023 13:44
As part of their blog series “Lighting The Way”, the BEAMER project interviews team members to discuss one of the six dimensions of quality care—safety, effectiveness, patient-centeredness, timeliness, efficiency, and equity—related to treatment adherence. For the second edition they spoke with Prof. Dr. João Filipe Raposo (Clinical Director of the patient...Read more

Link2Trials Q&A_2

Aad Liefveld
Q&A
246
c-a-2-09031619292.png
09-03-2023 16:05
In this Q&A series we answer questions we have received from our customer base. #2: How do we measure the effectiveness of online patient recruitment campaigns? We measure the effectiveness of our online patient recruitment campaigns by: Conversion rate: the percentage of visitors to a recruitment website who enroll in a study. Cost per enrolment: the total cost of the campaign...Read more

Link2Trials Q&A_1

Simon Klaasen
Q&A
360
q-a-1-02021941463.jpg
02-02-2023 19:46
In this Q&A series we answer questions we have received from our customer base. #1: When you integrate online patient recruitment, don't you create a bias in your clinical trial?Yes, there is a potential for bias in clinical trials that use online patient recruitment methods. The patient population reached through online channels may not be representative of the overall patient population...Read more

Medication Non-Adherence in Rheumatology, Oncology and Cardiology: A Review of the Literature of Risk Factors and Potential Interventions

Aad Liefveld
621
medication-non-adherence-in-rheumatology-oncology-and-cardiology-151118464410.jpg
31-10-2022 13:32
Medication Non-Adherence in Rheumatology, Oncology and Cardiology: A Review of the Literature of Risk Factors and Potential Interventions   A very interesting read, shared by our BEAMER colleagues at Pfizer. It identifies not only risk factors for adherence in three disease areas, but also the potentially most effective interventions to improve adherence. The conclusions of this...Read more

Over a year of hard work from the BEAMER team and the first deliverables are a fact.

Simon Klaasen
513
beamer-26sep-2022-06111328323.png
26-09-2022 13:27
Over a year of hard work from the BEAMER team and the first deliverables are a fact. Aad Liefveld shared the deliverables for Work Package 1, where the team analyzed the available literature to establish a solid background on the behavioral model that will be used. 32 theoretical behavioral models have been identified and analyzed in different areas like actionability and patient...Read more

Breederode University of Applied Sciences Rotterdam provides a 1-year specific training course for research nurses

Marjolein Nankman
401
breederode-8sep2022-06111305581.jpeg
08-09-2022 13:10
Again a very motivated group of Research Nurses becoming experts in their field. Simon Klaasen is happy to contribute with our knowledge of patient recruitment strategies. Breederode University of Applied Sciences Rotterdam provides a 1-year specific training course for research nurses/clinical trial coordinators to become experts in the field of setting up and supporting clinical...Read more

PSL (Patient Site Liaison) journey at Link2Trials

Stephanie Gontijo
390
stephanie-gontijo-06111257377.jpeg
07-09-2022 12:57
My name is Stephanie Maria Gontijo dos Santos Lima and I want to share a bit about my journey in the last 4 years with Link2Trials.During the last years of my medical studies, I worked as a PSL for different clinical trials in different countries: from Spain, UK to USA and for studies recruiting people with conditions such as back pain, to diabetes or cancer. Working with recruiting...Read more

An interesting discussion about DCT

Aad Liefveld
377
have-dcts-run-their-course-15111856265.jpg
30-08-2022 12:49
An interesting discussion about DCT An interesting discussion about DCT, started by Moe Alsumidaie.As a service provider we have supported a number of DCT’s. Some designs worked out fine for patients and sites, others not so much. From what we have seen so far, the successful ones were not technology or decentralization driven but made sensible choices about what could easily be...Read more

A must-read for anyone who wants to understand what impact tailored behavioral interventions can have on adherence!

Simon Klaasen
358
ontwerp-zonder-titel-16111037084.png
17-08-2022 12:43
A must-read for anyone who wants to understand what impact tailored behavioral interventions can have on adherence! This is precisely why we have developed our adherence support services for clinical studies. Thank you for sharing your insights, Dr Katerina Kassavou, Chimweta Chilala and Professor Stephen Sutton of the University of Cambridge. Read more  Read more

A model to predict adherence behavior

LUISA CARMO
368
beamer-05112106266.jpg
27-05-2022 21:05
At Link2Trials we are excited to be part of this latest initiative to develop a model to predict adherence behavior. This model will help healthcare providers to better support patients and enable the pharma industry to develop better products and services.   What a great BEAMER team we have! So many wonderful, interesting and foremost focused and motivated people!...Read more

Patient Site Liaison (PSL)

Claire Davis
340
claire-post-07apr2022-05112016569.jpeg
08-04-2022 20:17
Link2Trials uses its PSL to ensure the potential trial participants we refer match the study in- and exclusion criteria. Claire speaking:I’ve recently started working in a Patient Site Liaison (PSL) research role with Link2Trials. The role requires contacting patients who have expressed an interest online for participating in research studies relevant to themselves. I was attracted to the...Read more

Partnerships can streamline your clinical trial

Aad Liefveld
356
how-partnership-can-streamline-your-next-clinical-trial-17111414116.jpg
12-05-2022 20:08
Did you miss the webonar about how partnerschips can streamline your next clinical trial from Xtalks? Or did you join the live webinar but want to review the presentation, click below to watch the recording. In this webinar Simon Klaasen, Sandra Tobisch and Derk Arts, discussed: The importance of interoperability to reduce site and patient burden Considerations for...Read more

Beamer

Aad Liefveld
396
beamer-28-3-22-17111424249.png
05-11-2022 19:50
  Did you miss last week's BEAMER webinar?     Kicking off our BEAMER webinar series this month, we explore the scope of non-adherence with expert panelists from across the EU.BEAMERBEhavioral and Adherence Model for improving quality, health outcomes and cost-Effectiveness of healthcaRe       Click below and watch...Read more

Decentralized Clinical Trials

Marjolein Nankman
338
decentralized-clinical-trials-17111428351.jpg
28-03-2022 19:40
Heads up! Looking for a seamless experience for patients within your decentralized clinical trial?Because of their patient-centric approach DCTs will address important patient needs that often go unmet in a traditional, site-based set-up. By nature DCTs make clinical trial participation less burdensome, enable a more representative patient access, help develop a stronger evidence package and...Read more

Breederode University course for research nurses

Marjolein Nankman
307
breederode-05111923056.jpeg
25-03-2022 19:23
Breederode University of Applied Sciences Rotterdam provides a 1-year specific training course for research nurses/clinical trial coordinators to become experts in the field of setting up and supporting clinical trials. Great to see that this course has a specific focus on patient recruitment. This afternoon Simon Klaasen will give a guest lecture and share his expertise in the field of patient...Read more

How to Improve Medical Device Clinical Trials With The Right Partner Ecosystem

Simon Klaasen
467
castor-blogpost-021121035410.jpg
01-11-2022 09:57
Partnerships are a key to success when it comes time for your company’s next clinical trial. In this blog post, we will illustrate how building an effective partnership ecosystem can speed up timelines while optimizing operational activities in a clinical trial while highlighting a recent success story between Essity, Link2Trials, and Castor.   How to integrate partnerships to...Read more

PRESS RELEASE: clinical study for our lead product, pHyph, a vaginal tablet for topical treatment of bacterial vaginosis (BV), completes recruitment!

Edwin Swart
411
gedea-press-release-02112052568.jpg
10-02-2022 11:46
"Really fantastic feeling to have finalized enrolment of the 150 patients in our placebo-controlled study in bacterial vaginosis #Nefertiti - What an achievement by the Gedea Biotech AB team, the sites, LINK Medical Research, Link2Trials - and what a milestone for us!"  Read the full press release on the Gedea Biotech AB website: Link PRESS RELEASE: clinical study for our lead...Read more

Decentralized trials are here to stay.

Marjolein Nankman
311
essity-case-study-02112051027.jpg
19-01-2022 11:46
Decentralized trials are here to stay!  Read more

Decentralized trials

Simon Klaasen
403
decentralized-clinical-trials-are-here-to-stay-02112046096.jpg
13-01-2022 11:46
Not just for a pandemic: Decentralized trials "are here to stay, and they should be deployed in a fit-for-purpose manner" Decentralized clinical trials are here to stay, and the long-term benefits outweigh the higher initial costs and technical challenges of remote...Read more

Patient Site Liaison (PSL)

Tamara Schouten
330
whatsapp-image-2021-11-16-at-10-51-41-01111227005.jpg
16-11-2021 11:46
Link2Trials uses its PSLs to ensure the potential trial participants we refer fit the study in and exclusion criteria. My name is Tamara. I have been working as a Patient Site Liaison (PSL) at LinkTrials for several years now. As a PSL you are the link between a large number of applications and the actual (potential) participants for a clinical study. With a medically relevant background,...Read more

BEAMER project; BEhavioral and Adherence Model for improving quality, health outcomes and cost-Effectiveness of healthcaRe

Aad Liefveld
386
beamer-logo-yellow-blue--02112039095.jpg
10-11-2021 11:46
It doesn't get more patient centric than this!BEAMER the latest EFPIA - European Federation of Pharmaceutical Industries and Associations Innovative Medicines Initiative (IMI) initiative is about finding a new and effective way to improve patient adherence to treatment.  BEAMER will focus on assessing and understanding patient needs. At Link2Trials we are honored to be part...Read more

Choose category

Latest posts

link2trials

Tell us more. Solutions from Link2Trials go one step further. Let us know your goals

Thank you we will contact you soon
An error occurred. Please try again

Link2Trials

  • 1223 HL Hilversum
  • The Netherlands
  • Chamber of Commerce: 32122355

Privacy statement

beamer
eu
imi
efpia